Periodic safety reporting schedule
Active Substances | Trade Name | MAH | Year of registration in Saudi Arabia | International Birth Date (IBD) | PSUR Submission Frequency | Data Lock Point (DLP) | Submission Date |
---|---|---|---|---|---|---|---|
Ofatumumab | Arzerra | NOVARTIS | annual | ||||
Pasireotide | Signifor | NOVARTIS | annual | ||||
Metoclopramide | CLOPRAM | Jazeera Pharmaceutical Industries (JPI) | 3 years | ||||
Metoclopramide | PRIMPERAN 10mg | SANOFI PASTEUR | 3 years | ||||
Levofloxacin | LEVONIC | Jazeera Pharmaceutical Industries (JPI) | 3 years | ||||
Levofloxacin | Tavanic | SANOFI PASTEUR | 3 years | ||||
Levofloxacin | NEVOTIC | Pharma International Co | 3 years | ||||
DICLOFENAC SODIUM | DICLON 1% EMULGEL | MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES | 3 years | ||||
Insulin aspart | NovoMix 30 Penfill | NOVO NORDISK | 3 years | ||||
Diclofenac (topical ) | INFLA-BAN | APM | 3 years |